These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17397610)

  • 1. [Comparative study of maintenance of patency of triple lumen central venous catheter].
    Fuentes i Pumarola C; Casademont Mercader R; Colomer Plana M; Cordón Bueno C; Sabench Casellas S; Félez Vidal M; Rodríguez Plazas E
    Enferm Intensiva; 2007; 18(1):25-35. PubMed ID: 17397610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin or 0.9% sodium chloride to maintain central venous catheter patency: a randomized trial.
    Schallom ME; Prentice D; Sona C; Micek ST; Skrupky LP
    Crit Care Med; 2012 Jun; 40(6):1820-6. PubMed ID: 22488006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Keeping central venous lines open: a prospective comparison of heparin, vitamin C and sodium chloride sealing solutions in medical patients.
    Rabe C; Gramann T; Sons X; Berna M; González-Carmona MA; Klehr HU; Sauerbruch T; Caselmann WH
    Intensive Care Med; 2002 Aug; 28(8):1172-6. PubMed ID: 12185445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effectiveness of heparin versus 0.9% saline solution in maintaining the permeability of central venous catheters: a systematic review].
    Santos EJ; Nunes MM; Cardoso DF; Apóstolo JL; Queirós PJ; Rodrigues MA
    Rev Esc Enferm USP; 2015 Dec; 49(6):999-1007. PubMed ID: 27419685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of heparinization in prolonging patency of arterial and central venous catheters in children: a randomized double-blind trial.
    de Neef M; Heijboer H; van Woensel JB; de Haan RJ
    Pediatr Hematol Oncol; 2002 Dec; 19(8):553-60. PubMed ID: 12487830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal saline versus heparin for patency of central venous catheters in adult patients - a systematic review and meta-analysis.
    Zhong L; Wang HL; Xu B; Yuan Y; Wang X; Zhang YY; Ji L; Pan ZM; Hu ZS
    Crit Care; 2017 Jan; 21(1):5. PubMed ID: 28063456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of intravenous heparin to prevent thrombosis of central venous catheter in children.
    Bracho-Blanchet E; Cortés-Sauza J; Dávila-Pérez R; Lezama-Del Valle P; Villalobos-Alfaro C; Nieto-Zermeño J
    Cir Cir; 2010; 78(5):423-9. PubMed ID: 21219813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer.
    Cesaro S; Tridello G; Cavaliere M; Magagna L; Gavin P; Cusinato R; Zadra N; Franco Zanon G; Zanesco L; Carli M
    J Clin Oncol; 2009 Apr; 27(12):2059-65. PubMed ID: 19273702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin versus 0.9% sodium chloride intermittent flushing for the prevention of occlusion in long term central venous catheters in infants and children: A systematic review.
    Bradford NK; Edwards RM; Chan RJ
    Int J Nurs Stud; 2016 Jul; 59():51-9. PubMed ID: 27222450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of heparin and 0.9% sodium chloride solutions in maintenance of patency of central venous catheters.
    Heidari Gorji MA; Rezaei F; Jafari H; Yazdani Cherati J
    Anesth Pain Med; 2015 Apr; 5(2):e22595. PubMed ID: 25866710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The impact of heparin bolus from dysfunctional lumen of dual lumen central venous catheter on activated partial thromboplastin time during hemodialysis: is additional heparinization necessary?].
    Sefer S; Kes P; Raić B; Heinrich B; Degoricija V; Szavits-Nossan J
    Acta Med Croatica; 2006 Jun; 60(3):281-5. PubMed ID: 16933844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of heparin to citrate as a catheter locking solution for non-tunneled central venous hemodialysis catheters in patients requiring renal replacement therapy for acute renal failure (VERROU-REA study): study protocol for a randomized controlled trial.
    Bruyère R; Soudry-Faure A; Capellier G; Binquet C; Nadji A; Torner S; Blasco G; Yannaraki M; Barbar SD; Quenot JP
    Trials; 2014 Nov; 15():449. PubMed ID: 25409678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness of 30 % trisodium citrate and heparin lock solution in preventing infection and dysfunction of hemodialysis catheters: a randomized controlled trial (CITRIM trial).
    Correa Barcellos F; Pereira Nunes B; Jorge Valle L; Lopes T; Orlando B; Scherer C; Nunes M; Araújo Duarte G; Böhlke M
    Infection; 2017 Apr; 45(2):139-145. PubMed ID: 27573387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium citrate 4% versus heparin as a lock solution in hemodialysis patients with central venous catheters.
    Yon CK; Low CL
    Am J Health Syst Pharm; 2013 Jan; 70(2):131-6. PubMed ID: 23292266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct cost of maintenance of totally implanted central venous catheter patency.
    Homo RFB; Lima AFC
    Rev Lat Am Enfermagem; 2018 Jul; 26():e3004. PubMed ID: 30020336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National survey of central venous catheter flushing in the intensive care unit.
    Sona C; Prentice D; Schallom L
    Crit Care Nurse; 2012 Feb; 32(1):e12-9. PubMed ID: 22298726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of heparinized catheter lock solutions on systemic anticoagulation in hemodialysis patients.
    Thomson PC; Morris ST; Mactier RA
    Clin Nephrol; 2011 Mar; 75(3):212-7. PubMed ID: 21329631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of heparin solution versus normal saline in maintaining patency of intravenous locks in neonates: a double blind randomized controlled study.
    Arnts IJ; Heijnen JA; Wilbers HT; van der Wilt GJ; Groenewoud JM; Liem KD
    J Adv Nurs; 2011 Dec; 67(12):2677-85. PubMed ID: 21722168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventions other than anticoagulants and systemic antibiotics for prevention of central venous catheter-related infections in children with cancer.
    Arora RS; Roberts R; Eden TO; Pizer B
    Cochrane Database Syst Rev; 2010 Dec; (12):CD007785. PubMed ID: 21154387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration.
    Reeves JH; Cumming AR; Gallagher L; O'Brien JL; Santamaria JD
    Crit Care Med; 1999 Oct; 27(10):2224-8. PubMed ID: 10548211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.